Wegovy, Ozempic regain weight as Indian generics fall behind
Mumbai: Novo Nordisk’s weight-loss GLP-1 drug semaglutide branded as Wegovy and Ozempic are clawing back their lost ground with steady month-on-month sales growth as the frenzy of Indian generics begins…
Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson
New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…








